{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:33:57Z","timestamp":1787931237037,"version":"build-2784847793"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","award":["IPP: 656-166-2025"],"award-info":[{"award-number":["IPP: 656-166-2025"]}],"id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bioorg.2026.109591","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:28:37Z","timestamp":1770049717000},"page":"109591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Integrating synthesis, pharmacological evaluation, and molecular dynamics simulation of novel 8-substituted theophylline hybrids as potential PDE-4B inhibitors, bronchodilators and antibacterial"],"prefix":"10.1016","volume":"172","author":[{"given":"Taha F.S.","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A.O.","family":"Yani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim M.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend","family":"Mamdoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed F.","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman A.M.","family":"Beshr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa M.","family":"Hayallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109591_bb0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2006.07.002","article-title":"Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma","volume":"547","author":"Deng","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109591_bb0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0091-6749(00)90066-6","article-title":"Epithelial-mesenchymal interactions in the pathogenesis of asthma","volume":"105","author":"Holgate","year":"2000","journal-title":"J. Allerg. Clinic. Immun."},{"key":"10.1016\/j.bioorg.2026.109591_bb0015","doi-asserted-by":"crossref","first-page":"12379","DOI":"10.2147\/JIR.S527640","article-title":"Identification of novel biomarkers associated with corticosteroid resistance in asthma by bioinformatics analysis and experimental validation","author":"Xuan","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.bioorg.2026.109591_bb0020","article-title":"Trends and disparities in the prevalence of circulatory disease risk factors among US adults from the National Health Interview Survey database (2019\u20132022)","volume":"25","author":"Yasmin","year":"2025","journal-title":"Intern. J. Cardiology Cardiovasc. Risk Prevent."},{"key":"10.1016\/j.bioorg.2026.109591_bb0025","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1021\/jm010837k","article-title":"Novel selective PDE4 inhibitors. Synthesis, structure-activity relationships, and molecular modeling of 4-(3, 4-dimethoxyphenyl)-2 H-phthalazin-1-ones and analogues","volume":"44","author":"Van der Mey","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0030","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/jhet.3311","article-title":"Recent synthetic approaches towards biologically potent derivatives\/analogues of theophylline","volume":"55","author":"Yousaf","year":"2018","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0035","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s12272-012-0805-4","article-title":"Design and synthesis of new 8-anilide theophylline derivatives as bronchodilators and antibacterial agents","volume":"35","author":"Hayallah","year":"2012","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bioorg.2026.109591_bb0040","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0090-1229(88)90087-6","article-title":"Theophylline and the immune response: in vitro and in vivo effects","volume":"48","author":"Scordamaglia","year":"1988","journal-title":"Clinic. Immun. Immunopath."},{"key":"10.1016\/j.bioorg.2026.109591_bb0045","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0091-6749(95)70312-8","article-title":"Theophylline attenuation of airway responses to allergen: comparison with cromolyn metered-dose inhaler","volume":"95","author":"Hendeles","year":"1995","journal-title":"J. allerg. clinic. immun."},{"key":"10.1016\/j.bioorg.2026.109591_bb0050","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1164\/ajrccm.151.6.7767539","article-title":"Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy","volume":"151","author":"Kidney","year":"1995","journal-title":"Americ. J. Resp. Crit. care med."},{"key":"10.1016\/j.bioorg.2026.109591_bb0055","first-page":"184","article-title":"1740 BROADWAY","volume":"147","author":"Rabe","year":"1993","journal-title":"NEW YORK, NY 10019"},{"key":"10.1016\/j.bioorg.2026.109591_bb0060","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJM199605233342107","article-title":"Theophylline in asthma","volume":"334","author":"Weinberger","year":"1996","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.bioorg.2026.109591_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12272-011-0101-8","article-title":"Design and synthesis of some new theophylline derivatives with bronchodilator and antibacterial activities","volume":"34","author":"Hayallah","year":"2011","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bioorg.2026.109591_bb0070","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejmech.2018.02.038","article-title":"Synthesis and molecular docking of new roflumilast analogues as preferential-selective potent PDE-4B inhibitors with improved pharmacokinetic profile","volume":"148","author":"Moussa","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0075","first-page":"1","article-title":"Phosphodiesterase 4B (PDE4B) inhibitors and their applications in recent years (2014 To early 2025)","author":"Zhang","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2026.109591_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.12.381","article-title":"Asthma and severity of blood stream infection caused by Escherichia coli: a population-based study","volume":"129","author":"Yang","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bioorg.2026.109591_bb0085","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jaci.2017.06.031","article-title":"Effect of home exposure to Staphylococcus aureus on asthma in adolescents","volume":"141","author":"Davis","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bioorg.2026.109591_bb0090","first-page":"606","article-title":"Staphylococcus aureus nasal colonization and asthma in adults: systematic review and meta-analysis","volume":"7","author":"Kim","year":"2019","journal-title":"J. Allerg. Clinic. Immun: In Pract."},{"key":"10.1016\/j.bioorg.2026.109591_bb0095","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.12659\/MSM.910854","article-title":"Correlations of inflammatory factors with intestinal flora and gastrointestinal incommensurate symptoms in children with asthma","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Mon.: Intern. Medic. J. Exper. Clinic. Res."},{"key":"10.1016\/j.bioorg.2026.109591_bb0100","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jaci.2006.02.045","article-title":"Are phosphodiesterase 4 inhibitors just more theophylline","volume":"117","author":"Boswell-Smith","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bioorg.2026.109591_bb0105","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/archinte.1994.00420120066007","article-title":"Comparison of patients\u2019 compliance with prescribed oral and inhaled asthma medications","volume":"154","author":"Kelloway","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bioorg.2026.109591_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/pulp.1994.1001","article-title":"Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes\u2014their potential utility in the therapy of asthma","volume":"7","author":"Nicholson","year":"1994","journal-title":"Pulm. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109591_bb0115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0022-3565(24)29537-9","article-title":"Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro","volume":"297","author":"Hatzelmann","year":"2001","journal-title":"J. pharm. exper. ther."},{"key":"10.1016\/j.bioorg.2026.109591_bb0120","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(05)67100-0","article-title":"Roflumilast\u2014an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial","volume":"366","author":"Rabe","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2026.109591_bb0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1476-5381.2011.01218.x","article-title":"Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease","volume":"163","author":"Rabe","year":"2011","journal-title":"Brit. J. pharmac."},{"key":"10.1016\/j.bioorg.2026.109591_bb0130","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1016\/j.bmc.2009.03.061","article-title":"Identification of PDE4B over 4D subtype-selective inhibitors revealing an unprecedented binding mode","volume":"17","author":"Kranz","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0135","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1021\/jm00294a016","article-title":"8-substituted theophyllines. In vitro inhibition of 3\u2032, 5\u2032-cyclic adenosine monophosphate phosphodiesterase and pharmacological spectrum in mice","volume":"14","author":"Goodsell","year":"1971","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0140","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1021\/jo50006a010","article-title":"Synthesis of 1-mono- and 1,3-Di-substituted 6-Aminouracils. Diuretic activity","volume":"16","author":"Papesch","year":"1951","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0145","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3987\/COM-07-S(W)15","article-title":"Synthesis of new 1,3,8-Trisubstituted Purine-2,6-diones and 1,3,6-Trisubstituted Thiazolo[2,3-f]purine-2,4-diones","volume":"74","author":"Famulok","year":"2007","journal-title":"HETERO"},{"key":"10.1016\/j.bioorg.2026.109591_bb0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-1993-25814","article-title":"General synthesis and properties of 1-Monosubstituted Xanthines","author":"M\u00fcller","year":"1993","journal-title":"Synthesis"},{"key":"10.1016\/j.bioorg.2026.109591_bb0155","first-page":"153","article-title":"Synthesis, anti-bronchoconstrictive, and antibacterial activities of some new 8-substituted-1, 3-dimethylxanthine derivatives","volume":"32","author":"Elgaher","year":"2009","journal-title":"Bull. Pharmac. Sci. Ass. Univ."},{"key":"10.1016\/j.bioorg.2026.109591_bb0160","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1016\/j.bmc.2006.03.023","article-title":"Evaluation of glycolamide esters of indomethacin as potential cyclooxygenase-2 (COX-2) inhibitors","volume":"14","author":"Khanna","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0165","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/j.polymer.2007.07.001","article-title":"Synthesis and characterization of novel polyimides derived from 2-amino-5-[4-(4\u2032-aminophenoxy) phenyl]-thiazole with some of dianhydride monomers","volume":"48","author":"Zhao","year":"2007","journal-title":"Polymer"},{"key":"10.1016\/j.bioorg.2026.109591_bb0170","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ejmech.2009.10.031","article-title":"Novel substituted and fused pyrrolizine derivatives: synthesis, anti-inflammatory and ulcerogenecity studies","volume":"45","author":"Abbas","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0223-5234(94)90099-X","article-title":"Synthesis, toxicological and pharmacological assessment of 7-substituted derivatives of 1, 3-dimethylxanthine","volume":"29","author":"Peikov","year":"1994","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0180","article-title":"Dialkyloxyphenyl hybrids as PDE4B inhibitors: design, synthesis, in vitro\/in vivo anti-inflammatory activity and in silico insights","volume":"108511","author":"Almatary","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0185","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.str.2004.10.004","article-title":"Structural basis for the activity of drugs that inhibit phosphodiesterases","volume":"12","author":"Card","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.bioorg.2026.109591_bb0190","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1517\/13543784.17.5.811","article-title":"Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma","volume":"17","author":"Field","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bioorg.2026.109591_bb0195","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.molcel.2004.07.005","article-title":"A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases","volume":"15","author":"Zhang","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2026.109591_bb0200","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/jps.21494","article-title":"Calculation of molecular lipophilicity: state-of-the-art and comparison of log P methods on more than 96,000 compounds","volume":"98","author":"Mannhold","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2026.109591_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106207","article-title":"Human dihydrofolate reductase inhibition effect of 1-Phenylpyrazolo [3, 4\u2013d] pyrimidines: synthesis, antitumor evaluation and molecular modeling study","volume":"129","author":"Salem","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0210","first-page":"445","article-title":"The calculation of polar surface area from first principles: An application of quantum chemical topology to drug design, ChemMedChem: chemistry enabling","volume":"3","author":"Bytheway","year":"2008","journal-title":"Drug Des. Discov."},{"key":"10.1016\/j.bioorg.2026.109591_bb0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1008719622770","article-title":"ACD\/log P method description","volume":"19","author":"Petrauskas","year":"2000","journal-title":"Persp. dr. disc. des."},{"key":"10.1016\/j.bioorg.2026.109591_bb0220","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1007\/s00044-013-0861-4","article-title":"Synthesis, anti-inflammatory evaluation, and docking studies of some new thiazole derivatives","volume":"23","author":"Deb","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.109591_bb0225","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/acs.jmedchem.3c01708","article-title":"Lead optimization of BIBR1591 to improve its telomerase inhibitory activity: design and synthesis of novel four chemical series with in silico, in vitro, and in vivo preclinical assessments","volume":"67","author":"Al-Karmalawy","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00044-012-0026-x","article-title":"Synthesis of coumarin-based 1,3,4-oxadiazol-2ylthio-N-phenyl\/benzothiazolyl acetamides as antimicrobial and antituberculosis agents","volume":"22","author":"Patel","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.109591_bb0235","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1039\/D4OB00096J","article-title":"Visible-light-induced C\u2013S bond formation in the synthesis of 2,4-disubstituted thiazoles through cascade difunctionalization of acetophenone: a greener approach","volume":"22","author":"Rajput","year":"2024","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0240","doi-asserted-by":"crossref","first-page":"12188","DOI":"10.1039\/D3CC03547F","article-title":"NH4 I-promoted electrosynthesis of 2-aminothiazole derivatives from ketone compounds and NH4 SCN","volume":"59","author":"Zhang","year":"2023","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2026.109591_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2023.133721","article-title":"TsNBr2 promoted cascade formation of C\u2013N and C\u2013S bond: Metal-free synthesis of 2-aminothiazoles from ketones or ketoximes using thiourea","volume":"149","author":"Loukrakpam","year":"2023","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.109591_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.129900","article-title":"Sodium alginate: biopolymeric catalyst for the synthesis of 2-amino-4-arylthiazole derivatives in aqueous medium","volume":"1231","author":"Gorji","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109591_bb0255","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/14756366.2018.1550752","article-title":"Synthesis and biological evaluation of thiazole derivatives as Lb SOD inhibitors","volume":"34","author":"Brito","year":"2019","journal-title":"J. Enz. Inh. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0260","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3390\/ph16070946","article-title":"Novel Thiazolidine-2,4-dione-trimethoxybenzene-thiazole hybrids as human topoisomerases inhibitors","volume":"16","author":"Sinicropi","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.109591_bb0265","doi-asserted-by":"crossref","first-page":"110","DOI":"10.24820\/ark.5550190.p010.534","article-title":"Synthesis and biological screening of diethyl [N-(thiazol-2-yl)carbamoyl]methylphosphonates","author":"Olawode","year":"2018","journal-title":"Arkivoc"},{"key":"10.1016\/j.bioorg.2026.109591_bb0270","first-page":"51","article-title":"Synthesis, antibacterial, antifungal, and antioxidant evaluation of some new THIAZOLE clubbed OXADIAZOLE derivatives","volume":"27","author":"Monga","year":"2017","journal-title":"IND. J. HETER. CHEM."},{"key":"10.1016\/j.bioorg.2026.109591_bb0275","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.tetlet.2016.01.079","article-title":"Synthesis and free radical scavenging activity of 2-alkyl\/arylchalcogenyl-N-(4-aryl-1,3-thiazol-2-yl)acetamide compounds","volume":"57","author":"Wolf","year":"2016","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2026.109591_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107843","article-title":"Muti-target rationale design of novel substituted N-phenyl-2-((6-phenylpyridazin-3-yl)thio)acetamide candidates as telomerase\/JAK1\/STAT3\/TLR4 inhibitors: in vitro and in vivo investigations","volume":"153","author":"Shaldam","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0285","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jhet.4430","article-title":"Novel fluoroquinolones containing 2-arylamino-2-oxoethyl fragment: design, synthesis, evaluation of antibacterial and antituberculosis activities and molecular modeling studies","volume":"59","author":"Kulaba\u015f","year":"2022","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0290","doi-asserted-by":"crossref","first-page":"489","DOI":"10.59467\/IJHC.2023.33.489","article-title":"New Benzotriazole derivatives: synthesis, Biological Assessment, In vivo Oral Toxicity Analysis, Docking Studies, Molecular Dynamics, and ADME Profiling","volume":"33","author":"Maiti","year":"2023","journal-title":"IJHC"},{"key":"10.1016\/j.bioorg.2026.109591_bb0295","article-title":"Design, synthesis, in silico studies, and antiproliferative evaluations of novel indolin-2-one derivatives containing 3-hydroxy-4-pyridinone fragment, bioorg. Med.L","volume":"70","author":"Shirvani","year":"2022","journal-title":"Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109591_bb0300","first-page":"2456","article-title":"\u201cClick chemistry\u201d inspired synthesis and antimicrobial evaluation of 1, 2, 4-triazolo [4, 3-a] pyridine linked 1, 4-disubstituted 1, 2, 3-triazole derivatives with amide functionalities","author":"Parmar","year":"2024","journal-title":"DSpace at ATMIYA UNIVERSITY"},{"key":"10.1016\/j.bioorg.2026.109591_bb0305","first-page":"188","article-title":"Synthesis, in silico study and antimicrobial evaluation of new selenoglycolicamides","volume":"30","author":"Souza","year":"2019","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.109591_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116318","article-title":"In silico and in vitro ADME-Tox analysis and in vivo pharmacokinetic study of representative pan-PDE inhibitors from the group of 7, 8-disubstituted derivatives of 1, 3-dimethyl-7H-purine-2, 6-dione","volume":"457","author":"W\u00f3jcik-Pszczo\u0142a","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109591_bb0315","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1469-7793.1999.0843p.x","article-title":"Regulation of baseline cholinergic tone in guinea-pig airway smooth muscle","volume":"518","author":"Kesler","year":"1999","journal-title":"J. Physiol."},{"key":"10.1016\/j.bioorg.2026.109591_bb0320","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0223-5234(89)90035-4","article-title":"Synthesis and antibronchospastic activity of theophylline thioacetal derivatives","volume":"24","author":"Grosa","year":"1989","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0325","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0223-5234(96)88233-X","article-title":"Synthesis and in vitro bronchospasmolytic activity of 8-aryl, heteroaryl or arylalkyl theophyllines","volume":"30","author":"Baziard-Mouysset","year":"1995","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0330","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1476-5381.1994.tb17156.x","article-title":"Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor","volume":"113","author":"Raeburn","year":"1994","journal-title":"Brit. J. pharmac."},{"key":"10.1016\/j.bioorg.2026.109591_bb0335","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmac. Exper. Therap."},{"key":"10.1016\/j.bioorg.2026.109591_bb0340","article-title":"Acute toxicity studies and determination of median lethal dose","volume":"917\u2013920","author":"Akhila","year":"2007","journal-title":"Curr. Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109591_bb0345","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JCM.00213-21","article-title":"Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100","volume":"59","author":"Humphries","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bioorg.2026.109591_bb0350","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JCM.01934-17","article-title":"CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests","volume":"56","author":"Humphries","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bioorg.2026.109591_bb0355","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/pathogens10020165","article-title":"The minimum inhibitory concentration of antibiotics: methods, interpretation, clinical relevance","volume":"10","author":"Kowalska-Krochmal","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.bioorg.2026.109591_bb0360","article-title":"Exploitation of novel pyrazolo [3, 4-d] pyrimidine scaffold tethered to thiazole as potential EGFR\/HER2 dual kinase inhibitor to overcome lapatinib resistant breast cancer: design, synthesis, in silico docking and molecular dynamic simulation","volume":"108671","author":"Salem","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0365","article-title":"Novel chalcone candidates as potential in vitro and in vivo anti-inflammatory agents: synthesis, in-silico docking, multitarget bio evaluation and molecular dynamic simulation","volume":"108540","author":"Ahmed","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0370","series-title":"2: Protein preparation wizard, epik, schr\u00f6dinger, llc, new york, ny","author":"Schr\u00f6dinger Release","year":"2021"},{"key":"10.1016\/j.bioorg.2026.109591_bb0375","series-title":"In Molecular Modeling of Proteins, Springer","first-page":"445","author":"S\u00f8rensen","year":"2014"},{"key":"10.1016\/j.bioorg.2026.109591_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108181","article-title":"Exploration of anti-inflammatory activity of pyrazolo [3, 4-d] pyrimidine\/1, 2, 4-oxadiazole hybrids as COX-2, 5-LOX and NO release inhibitors: design, synthesis, in silico and in vivo studies","volume":"156","author":"Aziz","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109591_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.141504","article-title":"Microwave assisted synthesis, biological assessment and in-silico studies of some new 5, 5\u2032-(phenylmethylene) bisuracil and dihydropyrido [2, 3-d: 6, 5-d\u2019] dipyrimidine derivatives as selective COX-2 inhibitors with potential anti-inflammatory activities","volume":"1331","author":"Hayallah","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109591_bb0390","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13568-025-01835-3","article-title":"Reprofiling lamivudine as an antibiofilm and anti-pathogenic agent against Pseudomonas aeruginosa","volume":"15","author":"Alyahyawy","year":"2025","journal-title":"AMB Express"},{"key":"10.1016\/j.bioorg.2026.109591_bb0395","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70101","article-title":"Repurposing Nitroimidazoles: a new frontier in combatting bacterial virulence and quorum sensing via in silico, in vitro, and in vivo insights","volume":"86","author":"Khafagy","year":"2025","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2026.109591_bb0400","article-title":"Pioneering 1, 3, 5-triaryl pyrazolines as promising dual inhibitors of COX-2 and 15-LOX endowed with potent anticancer activity: design, synthesis, and in silico study","volume":"109081","author":"Abdullah","year":"2025","journal-title":"Bioorg. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:57:13Z","timestamp":1784753833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826001276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":80,"alternative-id":["S0045206826001276"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109591","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating synthesis, pharmacological evaluation, and molecular dynamics simulation of novel 8-substituted theophylline hybrids as potential PDE-4B inhibitors, bronchodilators and antibacterial","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109591"}}